|
|
|
|
Two pharmaceutical giants have
raked in over $28 billion in sales for the pneumonia vaccine alone, yet
say they can’t afford to drop the price to $5 so that all children in
developing countries can be protected against the worst of childhood
killers. The companies keep snubbing us, so now we need your help to tell
them that children’s lives should be put before corporate profits. SIGN
OUR PETITION AND SHARE WIDELY.
|
|
|
|
|
|
|
We need your help to get two
pharmaceutical giants to reduce the price of a life-saving vaccine that
currently remains priced out of reach for millions of children in
developing countries.
|
|
|
Pfizer and GlaxoSmithKline
(GSK) are the only two producers of the life-saving pneumonia vaccine.
Many lives have been saved by this vaccine, but pneumonia still kills
nearly 1 million children every year.
|
|
|
In fact, 75% of children
around the world remain unprotected against pneumonia, the leading
infectious cause of childhood death worldwide.
|
|
|
|
|
Only about half of the world’s
countries have been able to start using the pneumonia vaccine produced by
Pfizer & GSK, known as the pneumococcal conjugate vaccine (PCV). One
major barrier is the high price.
|
|
|
Even at the lowest
global prices, it costs 68 times more today to vaccinate a child in
developing countries than it did in 2001 – nearly half of that increase
is due to the high price of the pneumonia vaccine alone. This means that
a growing number of developing countries can’t afford to buy the vaccine
to protect their children against this childhood killer. |
|
|
Pfizer & GSK have
collectively reported more than US$26 billion in global sales from this
vaccine. That’s almost three times the entire 20-year budget that Gavi,
the Vaccine Alliance, uses to provide 10 different vaccines in around 60
of the world’s poorest countries.
|
|
|
MSF has also struggled to get
long-term affordable access to the pneumonia vaccine to help vaccinate
some of the world’s most vulnerable children in humanitarian crises.
|
|
|
It’s time for Pfizer and GSK
to lower the price of the pneumonia vaccine to $5 per child for all
developing countries and humanitarian organisations – SIGN THE PETITION.
|
|
|
The lowest global price for
the pneumonia vaccine today is $10 per child, available to only the
poorest countries through Gavi. History has shown that with competition,
prices will inevitably come down. A producer in India is developing a
pneumonia vaccine that it has promised to sell for $6 per child – but it
won’t be available until at least 2019. Between now and then, as many as
4 million more children could die because they have not been vaccinated
against pneumonia. A more affordable pneumonia vaccine could help
reduce this unnecessary loss of life, so why wait any longer to lower the
price?
|
|
|
We need children’s lives to be
prioritized over more blockbuster revenues. Today, children are being
left unprotected in countries such as Indonesia, Iraq, Jordan, Lebanon,
Romania, Syria and Thailand, among many others. A child dies of pneumonia
every 35 seconds. Now’s the time to lower the price of the pneumonia
vaccine to $5 per child for all developing countries and for humanitarian
organisations, so more lives can be saved – SIGN THE PETITION.
|
|
|
|
|
Thanks for all your support,
|
|
|
Vivian, Francois, Kate,
Barbara, Kelly and the whole A FAIR SHOT team
|
|
|
|
|
|
